Hormone Therapy

Part I. Managing Perimenopausal and Postmenopausal Symptoms with the New Menopausal HT

1. FAQ: Definitions of Menopause and Biological Actions of Sex Steroids
Katherine Sherif

2. Principles of Practice
Katherine Sherif

3. Medical Association Guidelines, Post-2002/Women’s Health Initiative Findings
Katherine Sherif

4. Perimenopausal Symptoms: Hot Flushes and Night Sweats; Sleep Disturbances; Urogenital Discomfort; Sexual Libido Issues; Mood and Cognitive Changes
Katherine Sherif

5. FAQ: Bioidentical Hormones: Compounded and Non-compounded
Katherine Sherif

Part II. Prescription of HT

6. Transdermal Estrogen as Preferred Prescription for Perimenopausal Symptom Relief, and the Role of Progesterone
Katherine Sherif

7. The Significance of Hormone Routes of Administration
Katherine Sherif

8. Hormone Therapy: Individualizing Treatment Based Upon Perimenopausal Symptoms
Katherine Sherif

9. FAQ: HT Prescription
Katherine Sherif

Part III. Monitoring, Side Effects, Co-existing Conditions, and Ending Treatment

10. Hormone Therapy: Monitoring Effects and Side Effects
Katherine Sherif

11. FAQ: Evaluation of Abnormal Menstrual Bleeding
Katherine Sherif

12. FAQ: Ending HT
Katherine Sherif

13. FAQ: HT and Other Conditions: Uterine Fibroids, Autoimmune disease, Hypothyroidism, and History of Breast Cancer
Katherine Sherif

Part IV. The Medical and Cultural History of HT

14. History of HT Use: Controversies and Confusions
Katherine Sherif

15. The 2002 Women’s Health Initiative Study (WHI): What Did It Prove or Disprove? Future Directions
Katherine Sherif

Nyckelord: Medicine & Public Health, Internal Medicine, Primary Care Medicine, General Practice / Family Medicine, Obstetrics/Perinatology, Endocrinology, Cardiology